Increased vascular MMP-9 in mice lacking RNF213

Temporal profile of the vascular anatomy evaluated by 9.4-T magnetic resonance angiography and histopathological analysis in mice lacking RNF213: A susceptibility gene for moyamoya disease

(2014) Shinya Sonobe et al.   BRAIN RESEARCH

Genetics and Biomarkers of Moyamoya Disease: Significance ofRNF213as a Susceptibility Gene

(2014) Miki Fujimura et al.   Journal of Stroke

Comparison of Immunosuppressive and Immunomodulatory Cells in Keratoacanthoma and Cutaneous Squamous Cell Carcinoma

(2013) Y Kambayashi et al.   ACTA DERMATO-VENEREOLOGICA

The moyamoya disease susceptibility variant RNF213 R4810K (rs112735431) induces genomic instability by mitotic abnormality

(2013) Toshiaki Hitomi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Guidelines for Diagnosis and Treatment of Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis)

(2013) et al.   NEUROLOGIA MEDICO-CHIRURGICA

Homozygous c.l4576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease

(2012) S. Miyatake et al.   NEUROLOGY

Molecular Analysis of RNF213 Gene for Moyamoya Disease in the Chinese Han Population

(2012) Zhiyuan Wu et al.   PLoS One

Identification of RNF213 as a Susceptibility Gene for Moyamoya Disease and Its Possible Role in Vascular Development

(2011) Wanyang Liu et al.   PLoS One

A genome-wide association study identifies RNF213 as the first Moyamoya disease gene

(2010) Fumiaki Kamada et al.   JOURNAL OF HUMAN GENETICS

Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease

(2009) H. S. Kang et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease

(2009) Miki Fujimura et al.   SURGICAL NEUROLOGY